BAY-293

BAY-293

Catalog Number:
L002372713APE
Mfr. No.:
APE-B8385
Price:
$407
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          BAY-293 is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 21 nM [1].
          Members of the RAS family of GTPases (which comprises KRAS, NRAS, and HRAS) are major oncogenes, mutants of RAS occur in many human cancers. SOS1 is the guanine nucleotide exchange factor (GEF) and activator of RAS.
          BAY-293 efficiently disrupted the interaction between KRAS and its exchange factor SOS1. In cells with wild-type KRAS (K-562, MOLM-13), BAY-293 showed complete inhibition of the RAS-RAF-MEK-ERK pathway. In mutant KRAS cell line (NCI-H358, Calu-1), BAY-293 exhibited synergistic anti-proliferative effects with KRASG12C inhibitor ARS-853.

          [1] Hillig RC, Sautier B, Schroeder J, et al. Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction. Proc Natl Acad Sci U S A. 2019;116(7):2551–2560.

      • Properties
        • Alternative Name
          (R)-6,7-dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine
          CAS Number
          2244904-70-7
          Molecular Formula
          C25H28N4O2S
          Molecular Weight
          448.58
          Purity
          98.00%
          Solubility
          insoluble in H2O; ≥24 mg/mL in EtOH; ≥57.3 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    Butamben

    $164

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.